637 related articles for article (PubMed ID: 30578107)
1. Portal vein thrombosis and liver cirrhosis: Long-term anticoagulation is effective and safe.
Bergère M; Erard-Poinsot D; Boillot O; Valette PJ; Guillaud O; Chambon-Augoyard C; Dumortier J
Clin Res Hepatol Gastroenterol; 2019 Aug; 43(4):395-402. PubMed ID: 30578107
[TBL] [Abstract][Full Text] [Related]
2. Anticoagulation in Cirrhosis and Portal Vein Thrombosis Is Safe and Improves Prognosis in Advanced Cirrhosis.
Noronha Ferreira C; Reis D; Cortez-Pinto H; Tato Marinho R; Gonçalves A; Palma S; Leite I; Rodrigues T; Pedro AJ; Alexandrino P; Serejo F; Sobral Dias M; Ferreira P; Vasconcelos M; Damião F; Xavier Brito L; Baldaia C; Fatela N; Ramalho F; Velosa J
Dig Dis Sci; 2019 Sep; 64(9):2671-2683. PubMed ID: 30852769
[TBL] [Abstract][Full Text] [Related]
3. Clinical Impact and Safety of Anticoagulants for Portal Vein Thrombosis in Cirrhosis.
Pettinari I; Vukotic R; Stefanescu H; Pecorelli A; Morelli M; Grigoras C; Sparchez Z; Andreone P; Piscaglia F;
Am J Gastroenterol; 2019 Feb; 114(2):258-266. PubMed ID: 30538290
[TBL] [Abstract][Full Text] [Related]
4. Portal vein thrombosis after partial splenic embolization in liver cirrhosis: efficacy of anticoagulation and long-term follow-up.
Cai M; Zhu K; Huang W; Meng X; He K; Zhou B; Guo Y; Chen J; Shan H
J Vasc Interv Radiol; 2013 Dec; 24(12):1808-16. PubMed ID: 24099787
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of anticoagulation therapy with low molecular weight heparin for portal vein thrombosis in patients with liver cirrhosis.
Amitrano L; Guardascione MA; Menchise A; Martino R; Scaglione M; Giovine S; Romano L; Balzano A
J Clin Gastroenterol; 2010 Jul; 44(6):448-51. PubMed ID: 19730112
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of anticoagulation in non-malignant portal vein thrombosis in patients with liver cirrhosis.
Artaza T; Lopes M; Romero M; Gómez AZ; de la Cruz G; Sánchez JJ; González C; Gómez R
Gastroenterol Hepatol; 2018 Dec; 41(10):611-617. PubMed ID: 30049580
[TBL] [Abstract][Full Text] [Related]
7. Prospective evaluation of anticoagulation and transjugular intrahepatic portosystemic shunt for the management of portal vein thrombosis in cirrhosis.
Senzolo M; M Sartori T; Rossetto V; Burra P; Cillo U; Boccagni P; Gasparini D; Miotto D; Simioni P; Tsochatzis E; A Burroughs K
Liver Int; 2012 Jul; 32(6):919-27. PubMed ID: 22435854
[TBL] [Abstract][Full Text] [Related]
8. Anticoagulation Therapy for Portal Vein Thrombosis in Patients with Cirrhosis in a Tertiary Center Experience.
Florescu MM; Costache A; Iacob SM; Pietrareanu C; Ester C; Cerban R; Dumitru R; Grasu M; Lupescu I; Gheorghe L
J Gastrointestin Liver Dis; 2021 Sep; 30(3):374-379. PubMed ID: 34551038
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of anticoagulation on patients with cirrhosis and portal vein thrombosis.
Delgado MG; Seijo S; Yepes I; Achécar L; Catalina MV; García-Criado A; Abraldes JG; de la Peña J; Bañares R; Albillos A; Bosch J; García-Pagán JC
Clin Gastroenterol Hepatol; 2012 Jul; 10(7):776-83. PubMed ID: 22289875
[TBL] [Abstract][Full Text] [Related]
10. Anticoagulation treatment of portal vein thrombosis in a patient with cirrhosis awaiting liver transplantation: A case report.
Wang J; Chai JS; Zhang YM
Medicine (Baltimore); 2018 Jun; 97(26):e11183. PubMed ID: 29952969
[TBL] [Abstract][Full Text] [Related]
11. Portal vein thrombosis: yes or no on anticoagulation therapy.
Turon F; Hernández-Gea V; García-Pagán JC
Curr Opin Organ Transplant; 2018 Apr; 23(2):250-256. PubMed ID: 29432256
[TBL] [Abstract][Full Text] [Related]
12. Portal vein thrombosis in liver cirrhosis: incidence, management, and outcome.
Fujiyama S; Saitoh S; Kawamura Y; Sezaki H; Hosaka T; Akuta N; Kobayashi M; Suzuki Y; Suzuki F; Arase Y; Ikeda K; Kumada H
BMC Gastroenterol; 2017 Oct; 17(1):112. PubMed ID: 29070023
[TBL] [Abstract][Full Text] [Related]
13. Harmful and Beneficial Effects of Anticoagulants in Patients With Cirrhosis and Portal Vein Thrombosis.
La Mura V; Braham S; Tosetti G; Branchi F; Bitto N; Moia M; Fracanzani AL; Colombo M; Tripodi A; Primignani M
Clin Gastroenterol Hepatol; 2018 Jul; 16(7):1146-1152.e4. PubMed ID: 29066371
[TBL] [Abstract][Full Text] [Related]
14. Anticoagulation Favors Thrombus Recanalization and Survival in Patients With Liver Cirrhosis and Portal Vein Thrombosis: Results of a Meta-Analysis.
Wang L; Guo X; Xu X; De Stefano V; Plessier A; Noronha Ferreira C; Qi X
Adv Ther; 2021 Jan; 38(1):495-520. PubMed ID: 33155180
[TBL] [Abstract][Full Text] [Related]
15. Effects of Anticoagulants in Patients With Cirrhosis and Portal Vein Thrombosis: A Systematic Review and Meta-analysis.
Loffredo L; Pastori D; Farcomeni A; Violi F
Gastroenterology; 2017 Aug; 153(2):480-487.e1. PubMed ID: 28479379
[TBL] [Abstract][Full Text] [Related]
16. Anticoagulation for the treatment of portal vein thrombosis in liver cirrhosis: a systematic review and meta-analysis of observational studies.
Qi X; De Stefano V; Li H; Dai J; Guo X; Fan D
Eur J Intern Med; 2015 Jan; 26(1):23-9. PubMed ID: 25566699
[TBL] [Abstract][Full Text] [Related]
17. A prediction model for successful anticoagulation in cirrhotic portal vein thrombosis.
Rodriguez-Castro KI; Vitale A; Fadin M; Shalaby S; Zerbinati P; Sartori MT; Landi S; Pettinari I; Piscaglia F; Han G; Burra P; Simioni P; Senzolo M
Eur J Gastroenterol Hepatol; 2019 Jan; 31(1):34-42. PubMed ID: 30188408
[TBL] [Abstract][Full Text] [Related]
18. Anticoagulation and Transjugular Intrahepatic Portosystemic Shunt for the Management of Portal Vein Thrombosis in Cirrhosis: A Prospective Observational Study.
Lv Y; Bai W; Li K; Wang Z; Guo W; Luo B; Wang J; Wang Q; Wang E; Xia D; Li X; Yuan J; Han N; Niu J; Yin Z; Fan D; Han G
Am J Gastroenterol; 2021 Jul; 116(7):1447-1464. PubMed ID: 33630766
[TBL] [Abstract][Full Text] [Related]
19. Anticoagulation in non-malignant portal vein thrombosis is safe and improves hepatic function.
Scheiner B; Stammet PR; Pokorny S; Bucsics T; Schwabl P; Brichta A; Thaler J; Lampichler K; Ba-Ssalamah A; Ay C; Ferlitsch A; Trauner M; Mandorfer M; Reiberger T
Wien Klin Wochenschr; 2018 Jul; 130(13-14):446-455. PubMed ID: 29916054
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of anticoagulation therapy with different doses of enoxaparin for portal vein thrombosis in cirrhotic patients with hepatitis B.
Cui SB; Shu RH; Yan SP; Wu H; Chen Y; Wang L; Zhu Q
Eur J Gastroenterol Hepatol; 2015 Aug; 27(8):914-9. PubMed ID: 25856686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
